It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by immune ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov. 5, 2024 — Researchers employed analysis tools and machine learning algorithms to identify two genes linked to ...

A breakthrough in Taiwan could mean earlier diagnosis and personalized treatment for those suffering from arthritis and ...

Clinicians have called for a national osteoporosis strategy after new research showed up to 70 per cent of patients are not receiving appropriate treatment, and that osteoporotic fractures are one ...

[23] Thus, the options should be fully discussed ... goal is to provide cardiac protection and osteoporosis prophylaxis, then long-term treatment is needed, possibly over a lifetime.

suggesting they could be useful markers for diagnosing or treating both rheumatoid arthritis and osteoporosis,” said Lo. With ...

Rheumatoid arthritis is a common disease affecting an estimated 17 million people worldwide. The disease is caused by ...

It showed the majority of men (70 per cent) and women (54 per cent) found to be at very high risk of fracture were not on treatment. The international research team said a national osteoporosis ...

Protein Blocking Bone Development Could Hold Clues for Future Osteoporosis Treatment Oct. 11, 2024 — Scientists have identified a protein that blocks the activity of bone-forming cells ...

Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced the dosing ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...